Papi et al evaluated patients with Crohn's disease who achieved a clinical remission with corticosteroid therapy. They identified risk factors associated with clinical relapse and the need for additional corticosteroid therapy. The authors are from hospitals in Rome and Bari, Italy.

To read more or access our algorithms and calculators, please log in or register.